Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th Internat... von Ruiz-Irastorza, G, Cuadrado, MJ, Ruiz-Arruza, I, Brey, R, Crowther, M, Derksen, R, Erkan, D, Krilis, S, Machin, S, Pengo, V, Pierangeli, S, Tektonidou, M, Khamashta, M

Volltext

Belimumab in primary antiphospholipid syndrome von Yazici, A, Yazirli, B, Erkan, D

Volltext

Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease von Erkan, D, Unlu, O, Sciascia, S, Belmont, H M, Branch, D Ware, Cuadrado, M J, Gonzalez, E, Knight, J S, Uthman, I, Willis, R, Zhang, Z, Wahl, D, Zuily, S, Tektonidou, M G

Volltext

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome von Legault, K., Schunemann, H., Hillis, C., Yeung, C., Akl, E. A., Carrier, M., Cervera, R., Crowther, M., Dentali, F., Erkan, D., Espinosa, G., Khamashta, M., Meerpohl, J. J., Moffat, K., O'Brien, S., Pengo, V., Rand, J. H., Rodriguez Pinto, I., Thom, L., Iorio, A.

Volltext

APS ACTION – AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking von Erkan, D, Lockshin, MD

Volltext

Non-criteria manifestations of antiphospholipid syndrome von Erkan, D., Lockshin, MD

Volltext

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking... von Jesús, GR, Sciascia, S, Andrade, D, Barbhaiya, M, Tektonidou, M, Banzato, A, Pengo, V, Ji, L, Meroni, PL, Ugarte, A, Cohen, H, Branch, DW, Andreoli, L, Belmont, HM, Fortin, PR, Petri, M, Rodriguez, E, Cervera, R, Knight, JS, Atsumi, T, Willis, R, Nascimento, IS, Rosa, R, Erkan, D, Levy, RA

Volltext

A cross‐sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome von Erkan, D., Yazici, Y., Peterson, M. G., Sammaritano, L., Lockshin, M. D.

Volltext

The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature von Chighizola, C B, Andreoli, L, de Jesus, G Ramires, Banzato, A, Pons-Estel, G J, Erkan, D

Volltext

The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus von Taraborelli, M, Leuenberger, L, Lazzaroni, M G, Martinazzi, N, Zhang, W, Franceschini, F, Salmon, J, Tincani, A, Erkan, D

Volltext

Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus von Kozora, E, Filley, C M, Erkan, D, Uluğ, A M, Vo, A, Ramon, G, Burleson, A, Zimmerman, R D, Lockshin, M D

Volltext

FRI0314 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Clinical Database and Repository Analysis: The Impact of Systemic Lupus Ery... von Zuily, S., Andrade, D., Erkan, D., Tektonidou, M.

Volltext

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines von Asherson, R A, Cervera, R, de Groot, P G, Erkan, D, Boffa, M-C, Piette, J-C, Khamashta, M A, Shoenfeld, Y

Volltext

Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients von Kozora, E., Uluğ, A. M., Erkan, D., Vo, A., Filley, C. M., Ramon, G., Burleson, A., Zimmerman, R., Lockshin, M. D.

Volltext

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations von Cervera, R, Tektonidou, MG, Espinosa, G, Cabral, AR, González, EB, Erkan, D, Vadya, S, Adrogué, HE, Solomon, M, Zandman-Goddard, G, Shoenfeld, Y

Volltext

Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet? von Pierangeli, SS, Erkan, D.

Volltext

Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus von Everett, S T, Wolf, R, Contento, I, Haiduc, V, Richey, M, Erkan, D

Volltext

SAT0426 Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS Action) Clinical Database and Repository (“Registry”) Cluster Analysis for Identifica... von Zuily, S., Wahl, D., Erkan, D.

Volltext

Long term outcome of catastrophic antiphospholipid syndrome survivors von Erkan, D, Asherson, R A, Espinosa, G, Cervera, R, Font, J, Piette, J-C, Lockshin, M D

Volltext

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions von Cervera, R, Tektonidou, MG, Espinosa, G, Cabral, AR, González, EB, Erkan, D, Vadya, S, Adrogué, HE, Solomon, M, Zandman-Goddard, G, Shoenfeld, Y

Volltext